kongre.net
Welcome to kongre.net

Speaker

Daniel Shelly

Chief Business Development Officer, PolTREG

Daniel Shelly, Chief Business Development Officer at PolTREG, appears in the programmes of 2 conferences on kongre.net. Next: 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026).

Conferences
2
Keynotes
0
Upcoming
1

Upcoming appearances

Past appearances

More speakers at 4th Cell Therapy for Autoimmune Disease Summit 2026

  • Fred Aslan

    President & Chief Executive Officer, Artiva Biotherapeutics, Inc

  • Rena Baek

    Executive Director, Preclinical Development, Moderna

  • Michael Mingueneau

    Vice President, Immunology, Sail Biomedicines

  • Edward Zhang

    Co-Founder & Chief Executive Officer, Overland Therapeutics

  • Mark Bach

    Chief Medical Officer, GentiBio

  • Nathalie Belmonte

    Chief Science & Technical Officer, Quell Therapeutics

See all 21 speakers on the event page

More speakers at 11th CAR-TCR Summit 2026

  • James Adams

    Chief Technical Officer, Tr1x therapeutics

  • Stephan Krause

    Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb

  • Michael Mingueneau

    Vice President, Immunology, Sail Biomedicines

  • Nikhil Mutyal

    Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

  • Luke Pase

    Chief Technology Officer, Anocca AB

  • Hong Xin

    Senior Director, Oncology Scientific Innovation, Johnson & Johnson

See all 83 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Daniel Shelly, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].